Chronic granulomatous disease: Two decades of experience from a tertiary care centre in North West India

Journal of Clinical Immunology

Volumn 34, Issue 1, 2014, Pages 58-67

  Rawat, Amit ^a   Singh, Surjit ^a   Suri, Deepti ^a   Gupta, Anju ^a   Saikia, Biman ^a   Minz, Ranjana Walker ^a   Sehgal, Shobha ^a   Vaiphei, Kim ^a   Kamae, C ^b   Honma, K ^b   Nakagawa, N ^b   Imai, K ^b   Nonoyama, S ^b   Oshima, K ^c   Mitsuiki, N ^c   Ohara, O ^c   Chan, Koon Wing ^d   Lau, Yu Lung ^d  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^c KAZUSA DNA RESEARCH INSTITUTE   (Japan)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chronic granulomatous disease; CYBB gene; dihydrorhodamine; NADPH oxidase; NCF 1 gene

Indexed keywords

COTRIMOXAZOLE; CYTOCHROME B 245 BETA POLYPEPTIDE; DIHYDRORHODAMINE 123; ITRACONAZOLE; KETOCONAZOLE; NEUTROPHIL CYTOSOLIC FACTOR 1; NITROBLUE TETRAZOLIUM; PROTEIN; UNCLASSIFIED DRUG; VORICONAZOLE;

ABDOMINAL DISTENTION; ABDOMINAL PAIN; ANTIMICROBIAL THERAPY; ARTICLE; ASSAY; AUTOSOMAL RECESSIVE DISORDER; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DEVELOPING COUNTRY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC ANALYSIS; GRANULOCYTE; HEPATOMEGALY; HUMAN; INDIA; INFANT; INTESTINE OBSTRUCTION; LIVER ABSCESS; LOOSE FECES; LYMPHADENITIS; MALE; MICROORGANISM; MOLECULAR DIAGNOSIS; NEWBORN; PNEUMONIA; PRIORITY JOURNAL; RECURRENT DISEASE; SEPSIS; SKIN ABSCESS; TERTIARY CARE CENTER; X CHROMOSOME LINKED DISORDER;

AGE OF ONSET; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; GRANULOMATOUS DISEASE, CHRONIC; HOSPITAL MORTALITY; HUMANS; INDIA; INFANT; INFANT, NEWBORN; INFECTION; MALE; MUTATION; PROGNOSIS; TERTIARY CARE CENTERS;

EID: 84896721647     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9963-5     Document Type: Article

References (37)

1. Winkelstein JA, Marino MC, Johnston Jr RB, Boyle J, Curnutte J, Gallin JI, et al. Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore). 2000;79(3):155-69.
2. Janeway CACJ, Davidson M, Downey W, Gitlin D, Sullivan JC. Hypergammaglobulinemia associated with severe, recurrent, and chronic non-specific infection. Am J Dis Child. 1954;88:388-92.
3. Berendes H, Bridges RA, Good RA. A fatal granulomatosus of childhood: the clinical study of a new syndrome. Minn Med. 1957;40(5):309-12.
4. Bridges RA, Berendes H, Good RA. A fatal granulomatous disease of childhood; the clinical, pathological, and laboratory features of a new syndrome. Am J Dis Child. 1959;97(4):387-408.
5. Kuijpers T, Lutter R. Inflammation and repeated infections in CGD: two sides of a coin. Cell Mol Life Sci. Jan;69(1):7-15.
6. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci STKE. 2006;2006(349):re8.
7. Matute JD, Arias AA, Wright NA, Wrobel I, Waterhouse CC, Li XJ, et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity. Blood. 2009;114(15):3309-15.
8. Park BH, Holmes BM, Rodey GE, Good RA. Nitroblue-tetrazolium test in children with fatal granulomatous disease and newborn infants. Lancet. 1969;1(7586):157.
9. Baehner RL, Nathan DG. Quantitative nitroblue tetrazolium test in chronic granulomatous disease. N Engl J Med. 1968;278(18):971-6.
10. Emmendorffer A, Hecht M, Lohmann-Matthes ML, Roesler J. A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123. J Immunol Methods. 1990;131(2):269-75.
11. Roesler J, Hecht M, Freihorst J, Lohmann-Matthes ML, Emmendorffer A. Diagnosis of chronic granulomatous disease and of its mode of inheritance by dihydrorhodamine 123 and flow microcytofluorometry. Eur J Pediatr. 1991;150(3):161-5.
12. Salaria M, Singh S, Kumar L, Datta U, Sehgal S. Chronic granulomatous disease. Indian Pediatr. 1999;36(6):594-6.
13. Nair PS, Moorthy PK, Suprakasan S, Jayapalan S, Preethi K. Chronic granulomatous disease. Indian J Dermatol Venereol Leprol. 2005;71(3):199-201.
14. Pinto LM, Udwadia ZF. A 24-year-old man with giddiness, hemoptysis, and skin lesions. Chest. 2008;134(5):1084-7.
15. Soneja M, Batra A, Vikram NK, Ahuja A, Mohan A, Sood R. Actinomycosis and nocardiosis co-infection in chronic granulomatous disease. J Assoc Physicians India. Apr;60:66-8.
16. Verma S, Sharma PK, Sivanandan S, Rana N, Saini S, Lodha R, et al. Spectrum of primary immune deficiency at a tertiary care hospital. Indian J Pediatr. 2008;75(2):143-8.
17. Ahlin A, De Boer M, Roos D, Leusen J, Smith CI, Sundin U, et al. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden. Acta Paediatr. 1995;84(12):1386-94.
18. Liese J, Kloos S, Jendrossek V, Petropoulou T, Wintergerst U, Notheis G, et al. Long-term follow-up and outcome of 39 patients with chronic granulomatous disease. J Pediatr. 2000;137(5):687-93.
19. Koker MY, Camcioglu Y, van Leeuwen K, Kilic SS, Barlan I, Yilmaz M, et al. Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients. J Allergy Clin Immunol. Jul 30.
20. El Kares R, Barbouche MR, Elloumi-Zghal H, Bejaoui M, Chemli J, Mellouli F, et al. Genetic and mutational heterogeneity of autosomal recessive chronic granulomatous disease in Tunisia. J Hum Genet. 2006;51(10):887-95.
21. Reich D, Thangaraj K, Patterson N, Price AL, Singh L. Reconstructing Indian population history. Nature. 2009;461(7263):489-94.
22. Martire B, Rondelli R, Soresina A, Pignata C, Broccoletti T, Finocchi A, et al. Clinical features, long-term follow-up and outcome of a large cohort of patients with Chronic Granulomatous Disease: an Italian multicenter study. Clin Immunol. 2008;126(2):155-64.
23. van den Berg JM, van Koppen E, Ahlin A, Belohradsky BH, Bernatowska E, Corbeel L, et al. Chronic granulomatous disease: the European experience. PLoS One. 2009;4(4):e5234.
24. Finn A, Hadzic N, Morgan G, Strobel S, Levinsky RJ. Prognosis of chronic granulomatous disease. Arch Dis Child. 1990;65(9):942-5.
25. van Montfrans JM, Rudd E, van de Corput L, Henter JI, Nikkels P, Wulffraat N, et al. Fatal hemophagocytic lymphohistiocytosis in X-linked chronic granulomatous disease associated with a perforin gene variant. Pediatr Blood Cancer. 2009;52(4):527-9.
26. Parekh C, Hofstra T, Church JA, Coates TD. Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease. Pediatr Blood Cancer. Mar;56(3):460-2.
27. Alvarez-Cardona A, Rodriguez-Lozano AL, Blancas-Galicia L, Rivas-Larrauri FE, Yamazaki-Nakashimada MA. Intravenous immunoglobulin treatment for macrophage activation syndrome complicating chronic granulomatous disease. J Clin Immunol. Apr;32(2):207-11.
28. Lee PP, Chan KW, Jiang L, Chen T, Li C, Lee TL, et al. Susceptibility to mycobacterial infections in children with X-linked chronic granulomatous disease: a review of 17 patients living in a region endemic for tuberculosis. Pediatr Infect Dis J. 2008;27(3):224-30.
29. Bustamante J, Aksu G, Vogt G, de Beaucoudrey L, Genel F, Chapgier A, et al. BCG-osis and tuberculosis in a child with chronic granulomatous disease. J Allergy Clin Immunol. 2007;120(1):32-8.
30. Bustamante J, Arias AA, Vogt G, Picard C, Galicia LB, Prando C, et al. Germline CYBB mutations that selectively affect macrophages in kindreds with X-linked predisposition to tuberculous mycobacterial disease. Nat Immunol. Mar;12(3):213-21.
31. Hasui M. Chronic granulomatous disease in Japan: incidence and natural history. The Study Group of Phagocyte Disorders of Japan. Pediatr Int. 1999;41(5):589-93.
32. Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C. Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr. 1989;114(4 Pt 1):555-60.
33. Roos D, Kuhns DB, Maddalena A, Roesler J, Lopez JA, Ariga T, et al. Hematologically important mutations: X-linked chronic granulomatous disease (third update). Blood Cells Mol Dis. Oct 15;45(3):246-65.
34. Roos D, Kuhns DB, Maddalena A, Bustamante J, Kannengiesser C, de Boer M, et al. Hematologically important mutations: the autosomal recessive forms of chronic granulomatous disease (second update). Blood Cells Mol Dis. Apr 15;44(4):291-9.
35. Casimir CM, Bu-Ghanim HN, Rodaway AR, Bentley DL, Rowe P, Segal AW. Autosomal recessive chronic granulomatous disease caused by deletion at a dinucleotide repeat. Proc Natl Acad Sci U S A. 1991;88(7):2753-7.
36. Gorlach A, Lee PL, Roesler J, Hopkins PJ, Christensen B, Green ED, et al. A p47-phox pseudogene carries the most common mutation causing p47-phox- deficient chronic granulomatous disease. J Clin Invest. 1997;100(8):1907-18.
37. Kuhns DB, Alvord WG, Heller T, Feld JJ, Pike KM, Marciano BE, et al. Residual NADPH oxidase and survival in chronic granulomatous disease. N Engl J Med. Dec 30;363(27):2600-10.